Cytokinetics' Myqorzo's trial results, Johnson & Johnson's IBD therapy, and more biotech news from The Readout
Kristoffer Tripplaar/AP
By Elaine Chen
May 5, 2026
National Biotech Reporter
Elaine Chen
New guidance for gene therapy developers, Lilly's deal for kidney drugs, and more biotech news from The Readout
RIP Sangamo, onshoring with drug manufacturing, and more biotech news from The Readout
The "triple-G" weight loss drug, Pfizer's lung cancer trial results, and more biotech news from The Readout
Eli Lilly announces two China deals, Akeso's lung cancer bispecific payoff, and more biotech news from The Readout
Alzheimer's drug rollout letdown, a China-based heart drug startup, and more biotech news from The Readout
Eli Lilly spends more of its GLP-1 cash, Humira's masterclass in monopoly, and more updates from The Readout
